Axon Enterprise, Inc. (NASDAQ:AXON) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Axon Enterprise, Inc. (NASDAQ:AXON) has received an average rating of “Moderate Buy” from the fourteen analysts that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $365.38.

A number of research firms have weighed in on AXON. Needham & Company LLC restated a “buy” rating and set a $400.00 price objective on shares of Axon Enterprise in a research report on Wednesday, August 7th. Jefferies Financial Group started coverage on shares of Axon Enterprise in a research note on Wednesday, July 17th. They issued a “buy” rating and a $385.00 price target on the stock. Craig Hallum boosted their price objective on Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research note on Wednesday, August 7th. JMP Securities raised their target price on Axon Enterprise from $375.00 to $430.00 and gave the company an “outperform” rating in a research report on Thursday, September 12th. Finally, Northland Securities boosted their price target on shares of Axon Enterprise from $330.00 to $365.00 and gave the stock an “outperform” rating in a research report on Thursday, August 8th.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 80,300 shares of the stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the sale, the chief executive officer now directly owns 3,015,366 shares in the company, valued at approximately $1,121,052,771.48. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other Axon Enterprise news, CEO Patrick W. Smith sold 75,000 shares of the stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $356.53, for a total value of $26,739,750.00. Following the sale, the chief executive officer now owns 2,970,366 shares of the company’s stock, valued at approximately $1,059,024,589.98. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Patrick W. Smith sold 80,300 shares of the business’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $371.78, for a total value of $29,853,934.00. Following the transaction, the chief executive officer now directly owns 3,015,366 shares of the company’s stock, valued at $1,121,052,771.48. The disclosure for this sale can be found here. Over the last quarter, insiders sold 317,981 shares of company stock worth $115,662,734. Corporate insiders own 6.10% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in shares of Axon Enterprise by 2.7% in the 1st quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company’s stock valued at $2,547,878,000 after purchasing an additional 212,401 shares during the last quarter. Sands Capital Management LLC increased its holdings in Axon Enterprise by 0.6% in the fourth quarter. Sands Capital Management LLC now owns 2,628,652 shares of the biotechnology company’s stock valued at $679,060,000 after buying an additional 16,347 shares during the last quarter. Motley Fool Asset Management LLC raised its stake in Axon Enterprise by 238.7% in the first quarter. Motley Fool Asset Management LLC now owns 492,140 shares of the biotechnology company’s stock valued at $153,981,000 after buying an additional 346,838 shares in the last quarter. 1832 Asset Management L.P. lifted its holdings in Axon Enterprise by 44.0% during the 2nd quarter. 1832 Asset Management L.P. now owns 375,700 shares of the biotechnology company’s stock worth $110,546,000 after buying an additional 114,800 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC boosted its position in shares of Axon Enterprise by 13.9% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 368,732 shares of the biotechnology company’s stock worth $108,496,000 after acquiring an additional 45,049 shares in the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Up 0.5 %

AXON opened at $395.34 on Friday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 2.52 and a current ratio of 2.88. Axon Enterprise has a fifty-two week low of $190.01 and a fifty-two week high of $398.74. The company has a fifty day moving average of $356.27 and a two-hundred day moving average of $320.06. The stock has a market capitalization of $29.88 billion, a price-to-earnings ratio of 115.60, a PEG ratio of 10.55 and a beta of 0.94.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Tuesday, August 6th. The biotechnology company reported $1.20 EPS for the quarter, beating the consensus estimate of $1.02 by $0.18. The company had revenue of $504.00 million for the quarter, compared to analyst estimates of $478.35 million. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. Axon Enterprise’s quarterly revenue was up 34.5% compared to the same quarter last year. During the same period last year, the company earned $0.80 earnings per share. On average, research analysts expect that Axon Enterprise will post 1.79 earnings per share for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.